Sculptra

Scluptra is an intersting injectable filling agent approves by the FDA for cosmetic use in 2008 after significant clinicial trials conducted in the USA and Europe. The unique product, when injected subdermally (just below the sking), stimulates new collagen formation resulting in dermal thickening and improvement in overlying skin laxity and wrinkles and textural improvement to the skin. In addition, it can be used for volume enhancement of the face to improve hollow areas such as the temples, under eye region, lateral face, and around the mouth area similar to other injectable fillers. Just like the autogenous fat transfer, Sculptra enhances vokume and can even achieve subtle skeletal augmentation of the face when desired. A series of about three injections using one or two vials for treatment six weeks apart is usually required for optimal results, which last more than two years. This procedure can be easily performed in the office setting since local anesthetic is incorporated in the injection of Sculptra. Proper dilution and postoperative, massage performed at the time of injections and at hiome by the patient are important to obtain optimal results and avoid small palpable bumps called papules after the treatment. In the hands of an experienced injector, Sculptra provides a unique combination of dermal rejuvenation and restoration as well as volume enhancement when desired.